Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis
Suzanne N. Landi(University of North Carolina at Chapel Hill), Hazel B. Nichols(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University), Jennifer M. Wu(University of North Carolina Health Care), Laura Hendrix(University of North Carolina at Chapel Hill), Kemi M. Doll(University of Washington), Jeannette T. Bensen(University of North Carolina at Chapel Hill)
Cited by 13
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
|Clinical Breast Cancer|2009|644